Evidence map›Paper›PMID 42233165›Full record

ArticleMed-X2026

Repurposing the skin to heal the body: Tissue Nanotransfection (TNT) as a therapeutic platform.

Ana I Salazar-Puerta, Kristin Stanford, Natalia Higuita-Castro, Daniel Gallego-Perez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Med-X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana I Salazar-PuertaDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH USA.
Kristin StanfordDepartment of Surgery, The Ohio State University, Columbus, OH USA.
Natalia Higuita-CastroDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH USA.
Daniel Gallego-PerezDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH USA.ORCID 0000-0002-6263-3191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue Nanotransfection (TNT) is an emerging and transformative platform for non-viral drug and gene delivery that enables highly efficient, precise, and rapid (millisecond-scale) transfer of molecular cargo into solid tissues. Using silicon nanochannels, TNT electrophoretically drives charged payloads ( Graphical Abstract:

Indexed as

In situ therapeutic manufacturingNon-viral gene deliveryOrgan-targeted deliveryRegenerative medicineTissue Nano-Transfection

Identifiers

PMID42233165
PMCPMC13222898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.